Historical record - last NADAC effective date: 8/20/2014
Product Information
CLINDACIN ETZ KIT is a brand (anda) product labeled by Medimetriks Pharmaceuticals Inc., priced at $289.8260 per EA under NDC 43538017360. Its NADAC has been published 38 times since Jan 22, 2014.
FDA first approved this application on May 25, 2000. Its Orange Book therapeutic-equivalence code is AT.
The High Outlier badge above means this manufacturer's average price in the clindamycin phosphate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Medimetriks Pharmaceuticals Inc.NDC
43538017360
Classification
Brand (ANDA)
Dosage Form
KIT
Effective Date
8/20/2014
Approval Type
Generic (ANDA)
FDA Application
ANDA065049FDA Approved
5/25/2000
TE Code
AT
On Market Since
6/15/2013
Price Statistics
The NADAC for CLINDACIN ETZ KIT has been published 38 times since Jan 22, 2014, and over the history we have for it it has risen 12.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $289.8260 per EA |
|---|---|
| All-time high | $289.8260 (Oct 8, 2014) |
| All-time low | $258.2720 (Jan 22, 2014) |
| Median price | $269.5070 |
| Average price | $271.1476 |
| Largest weekly change | +3.8% (Aug 20, 2014) |
| Weeks tracked | 38 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+12.2%
Last surveyed Oct 8, 2014 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the clindamycin phosphate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Medimetriks Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
clindamycin phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDACIN ETZ KIT?
The current National Average Drug Acquisition Cost (NADAC) for CLINDACIN ETZ KIT, manufactured by Medimetriks Pharmaceuticals Inc., is $289.8260 per EA (NDC 43538017360), effective Oct 8, 2014.
How has the price of CLINDACIN ETZ KIT changed over time?
Over the history we have for it, the NADAC for CLINDACIN ETZ KIT has risen 12.2%. It has been tracked across 38 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for CLINDACIN ETZ KIT?
Since Jan 22, 2014, the NADAC for CLINDACIN ETZ KIT has ranged from a low of $258.2720 (Jan 22, 2014) to a high of $289.8260 (Oct 8, 2014), with a median of $269.5070 per EA.
Are there cheaper alternatives to CLINDACIN ETZ KIT?
No other NADAC-published product currently shares the active ingredient and strength of CLINDACIN ETZ KIT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLINDACIN ETZ KIT?
CLINDACIN ETZ KIT (NDC 43538017360) is labeled by Medimetriks Pharmaceuticals Inc., and CMS classifies it as a brand (anda) product.